Prognostic parameter for high risk prostate cancer patients at initial presentation.

about

Prognostic parameter for high risk prostate cancer patients at initial presentation.

Item

http://www.wikidata.org/entity/Q47228566

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic parameter for high risk prostate cancer patients at initial presentation.

@en

Prognostic parameter for high risk prostate cancer patients at initial presentation.

@nl

type

Item

label

Prognostic parameter for high risk prostate cancer patients at initial presentation.

@en

Prognostic parameter for high risk prostate cancer patients at initial presentation.

@nl

prefLabel

Prognostic parameter for high risk prostate cancer patients at initial presentation.

@en

Prognostic parameter for high risk prostate cancer patients at initial presentation.

@nl

P1476

Prognostic parameter for high risk prostate cancer patients at initial presentation

@en

P2093

Akihiro Hirakawa

http://www.w3.org/2001/XMLSchema#string

Kyosuke Kimura

http://www.w3.org/2001/XMLSchema#string

Momokazu Gotoh

http://www.w3.org/2001/XMLSchema#string

Naoto Sassa

http://www.w3.org/2001/XMLSchema#string

Osamu Kamihira

http://www.w3.org/2001/XMLSchema#string

Ryo Ishida

http://www.w3.org/2001/XMLSchema#string

Ryohei Hattori

http://www.w3.org/2001/XMLSchema#string

Toyonori Tsuzuki

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Majima

http://www.w3.org/2001/XMLSchema#string

Yasuhito Funahashi

http://www.w3.org/2001/XMLSchema#string

P2860

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Aggressive variants of castration-resistant prostate cancer

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.

Intraductal carcinoma of the prostate: the whole story.

Intraductal carcinoma of the prostate: a comprehensive and updated review.

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.

The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation.

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

P304

11-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23438

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masashi Kato

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29094384

http://www.w3.org/2001/XMLSchema#string